News Precipio, Inc.

Stocks

PRPO

US74019L6020

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX 22:20:02 12/11/2026 +04			5-day change	1st Jan Change
22.83 ^USD	-7.94%		+24.85%	+1.00%

11-11	Precipio, Inc., Q3 2026 Earnings Call, Nov 10, 2026
11-11	Precipio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026	CI

All News

Mentions Relevance

6600afbae2c6d9266b6b08.9QcLmNEt8pIm8u7GDeTn6pgp9BcUp3G3xr9-NQMlyCs.oj5HqbkYs9AUvpSydK64uOtFmyZ_90WOkI9Gf1QR-F-4Xz_BmH6XwXOcpw

11-11	Precipio, Inc., Q3 2026 Earnings Call, Nov 10, 2026
11-11	Precipio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026	CI
08-18	Precipio, Inc., Q2 2026 Earnings Call, Aug 17, 2026
08-15	Precipio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-15	Precipio Announces Q2-2026 Financial Results	AQ
08-01	Precipio Announces Q2-2026 Shareholder Update Call	AQ
06-29	Precipio, Inc.(NasdaqCM:PRPO) added to Russell 3000E Index	CI
06-29	Precipio, Inc.(NasdaqCM:PRPO) added to Russell Microcap Index	CI
06-29	Precipio, Inc.(NasdaqCM:PRPO) added to Russell 3000E Growth Benchmark	CI
06-29	Precipio, Inc.(NasdaqCM:PRPO) added to Russell Microcap Growth Benchmark Index	CI
06-12	Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting	AQ
06-12	Precipio to Present at the Planet MicroCap Las Vegas	AQ
05-19	Precipio, Inc., Q1 2026 Earnings Call, May 18, 2026
05-15	Precipio Announces Q1 2026 Financial Results	AQ
05-15	Precipio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-14	Management team’s 2025 market-based Options have vested	AQ
05-07	Precipio Announces Q1-2026 Shareholder Update Call	AQ
04-03	Precipio, Inc., Q4 2025 Earnings Call, Apr 02, 2026
03-31	Precipio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-30	Precipio, Inc. Auditor Raises 'Going Concern' Doubt	CI
03-13	Precipio Announces Q4 and year-end 2025 Shareholder Update Call	AQ
03-11	Precipio Inc Announces Bloodhound BCR::ABL1 Assay For Chronic Myeloid Leukemia	CI
03-10	Precipio Announces Publication of a Joint Study with Memorial Sloan-Kettering Cancer Center Highlighting Its Cutting-Edge Bloodhound BCR::ABL1 Assay	AQ
02-25	Precipio 2025 (Unaudited) Revenues Grew to $24.0M, a 30% Increase Year-Over-Year	AQ
01-15	Precipio Takes Major Steps Toward a Clean Balance Sheet	AQ